CHERYL DAVIS-LAND: Open Payments
NPI 1740335702 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$121 in 2 payments from 2 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $121
Food & beverage: $121
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $85 |
| Neurocrine BioSciences, Inc. | 1 | $36 |
Products named: INGREZZA.
Industry payments across IN — which companies pay providers there.
